Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3401)
All Articles published online
|
Nov 21, 2010 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang Y, Speeg KV, Washburn WK, Halff G. Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report. World J Gastroenterol 2010; 16(43): 5518-5522 [PMID: 21086573 DOI: 10.3748/wjg.v16.i43.5518] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i43/5518.htm |
| Number | Citing Articles |
| 1 |
Filippo Pelizzaro, Martina Gambato, Enrico Gringeri, Alessandro Vitale, Umberto Cillo, Fabio Farinati, Patrizia Burra, Francesco Paolo Russo. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2021; 13(19): 4882 doi: 10.3390/cancers13194882
|
| 2 |
Umberto Cillo, Amedeo Carraro, Alfonso W. Avolio, Matteo Cescon, Fabrizio Di Benedetto, Valerio Giannelli, Paolo Magistri, Daniele Nicolini, Marco Vivarelli, Jacopo Lanari, Salvatore Agnes, Enzo Andorno, Umberto Baccarani, Lucio Caccamo, Michele Colledan, Luciano De Carlis, Paolo De Simone, Giuseppe Maria Ettorre, Salvatore Gruttadauria, Vincenzo Mazzaferro, Renato Romagnoli, Massimo Rossi, Francesco Tandoi, Giuseppe Tisone, Giovanni Vennarecci, Fausto Zamboni. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT). Updates in Surgery 2024; 76(3): 725 doi: 10.1007/s13304-024-01845-z
|
| 3 |
Claudio Zavaglia, Aldo Airoldi, Andrea Mancuso, Marcello Vangeli, Raffaella Viganò, Gabriella Cordone, Maria Gentiluomo, Luca Saverio Belli. Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation. European Journal of Gastroenterology & Hepatology 2013; 25(2): 180 doi: 10.1097/MEG.0b013e328359e550
|
| 4 |
Elizabeth C. Verna, Yuval A. Patel, Avin Aggarwal, Archita P. Desai, Catherine Frenette, Anjana A. Pillai, Reena Salgia, Anil Seetharam, Pratima Sharma, Courtney Sherman, Georgios Tsoulfas, Francis Y. Yao. Liver transplantation for hepatocellular carcinoma: Management after the transplant. American Journal of Transplantation 2020; 20(2): 333 doi: 10.1111/ajt.15697
|
| 5 |
Arndt Weinmann, Ina Maria Niederle, Sandra Koch, Maria Hoppe-Lotichius, Michael Heise, Christoph Düber, Marcus Schuchmann, Gerd Otto, Peter Robert Galle, Marcus-Alexander Wörns. Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. Digestive and Liver Disease 2012; 44(5): 432 doi: 10.1016/j.dld.2011.12.009
|
| 6 |
Jiwei Huang, Lunan Yan, Hong Wu, Jiayin Yang, Mingheng Liao, Yong Zeng. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?. Journal of Surgical Research 2016; 200(1): 122 doi: 10.1016/j.jss.2015.07.033
|
| 7 |
Daniel Hoffman, Neil Mehta. Recurrence of hepatocellular carcinoma following liver transplantation. Expert Review of Gastroenterology & Hepatology 2021; 15(1): 91 doi: 10.1080/17474124.2021.1823213
|
| 8 |
Hidetoshi Nitta, Aline Younès, Nada El‐domiaty, Vincent Karam, Rodolphe Sobesky, Eric Vibert, Audrey Coilly, Teresa Maria Antonini, Eleonora De Martin, Daniel Cherqui, Hideo Baba, Olivier Rosmorduc, René Adam, Didier Samuel, Faouzi Saliba. High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients. Transplant International 2021; 34(7): 1293 doi: 10.1111/tri.13897
|
| 9 |
Martin-Walter Welker, Wolf-Otto Bechstein, Stefan Zeuzem, Joerg Trojan. Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge. Transplant International 2013; 26(2): 109 doi: 10.1111/j.1432-2277.2012.01562.x
|
| 10 |
Quan-Lin Li, Fang-Ming Gu, Zheng Wang, Jia-Hao Jiang, Li-Qing Yao, Chang-Jun Tan, Xiao-Yong Huang, Ai-Wu Ke, Zhi Dai, Jia Fan, Jian Zhou, Xin-yuan Guan. Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma. PLoS ONE 2012; 7(3): e33379 doi: 10.1371/journal.pone.0033379
|
| 11 |
Eric Davis, Russell Wiesner, Juan Valdecasas, Yoshiaki Kita, Massimo Rossi, Myron Schwartz. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Liver Transplantation 2011; 17(S2): S162 doi: 10.1002/lt.22361
|
| 12 |
Nicola de’Angelis, Filippo Landi, Maria Clotilde Carra, Daniel Azoulay. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review. World Journal of Gastroenterology 2015; 21(39): 11185-11198 doi: 10.3748/wjg.v21.i39.11185
|
| 13 |
Elisa Feller Gonçalves Da Silva, Gabriele Catyana Krause, Kelly Goulart Lima, Gabriela Viegas Haute, Leonardo Pedrazza, Fernanda Cristina Mesquita, Bruno Souza Basso, Anderson Catarina Velasquez, Fernanda Bordignon Nunes, Jarbas Rodrigues De Oliveira. Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis. Oncology Reports 2016; 36(5): 2647 doi: 10.3892/or.2016.5111
|
| 14 |
Gyula Végső, Dénes Görög, Imre Fehérvári, Balázs Nemes, Attila Doros, Róbert Miklós Langer, László Kóbori. Role of Organ Transplantation in the Treatment of Malignancies – Hepatocellular Carcinoma as the Most Common Tumour Treated with Transplantation. Pathology & Oncology Research 2012; 18(1): 1 doi: 10.1007/s12253-011-9441-4
|
| 15 |
G.C. Sotiropoulos, K.W. Nowak, I. Fouzas, S. Vernadakis, S. Kykalos, C.G. Klein, A. Paul. Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation. Transplantation Proceedings 2012; 44(9): 2754 doi: 10.1016/j.transproceed.2012.09.022
|
| 16 |
|
| 17 |
H.Y. Lee, K.H. Yang, B.H. Choi, Y.M. Park, K.T. Yoon, J.H. Ryu, C.W. Chu. Complete Regression of Recurrent Advanced Hepatocellular Carcinoma After Liver Transplantation in Response to Sorafenib Treatment: A Case Report. Transplantation Proceedings 2016; 48(1): 247 doi: 10.1016/j.transproceed.2015.11.012
|
| 18 |
Guanghan Fan, Xuyong Wei, Xiao Xu. Is the era of sorafenib over? A review of the literature. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920927602
|
| 19 |
Young Mi Hong, Ki Tae Yoon, Mong Cho, Dae Hwan Kang, Hyung Wook Kim, Cheol Woong Choi, Su Bum Park, Jeong Heo, Hyun Young Woo, Won Lim. Sorafenib in the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Report of Four Cases. The Korean Journal of Gastroenterology 2015; 65(4): 246 doi: 10.4166/kjg.2015.65.4.246
|
| 20 |
Yasunobu Matsuda, Takafumi Ichida, Manabu Fukumoto. Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies. Medical Molecular Morphology 2011; 44(3): 117 doi: 10.1007/s00795-011-0547-2
|
| 21 |
Martin-Walter Welker, Jörg Trojan. Rezidiv des hepatozellulären Karzinoms nach orthotoper Lebertransplantation: Nachsorge und therapeutische Optionen. Viszeralmedizin 2012; 28(5): 338 doi: 10.1159/000343684
|
| 22 |
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
|